SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy

SUDOSCAN in Oncology : Chemotherapy InduCed Polyneuropathy Two studies evaluating SUDOSCAN   Severe drug-induced neurotoxic adverse effects constitute the second most common cause of dose limitation after haematological adverse effects.  Chemotherapy Induced Polyneuropathy (CIPN) is commonly associated with platinum analogues, antitubulins (taxane), the proteasome inhibitor bortezomib, and thalidomide. However, it is poorly investigated at an …

SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy Read More »